Why are (some) conflicts of interest in medicine so uniquely vexing?

Conflicts of Interest: Challenges and Solutions in Business, Law, Medicine, and Public Policy

Volumn , Issue , 2005, Pages 152-180

  Stark, Andrew ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 31144454338     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511610332.012     Document Type: Chapter

References (116)

1. Ad Hoc Committee on Misconduct and Conflict of Interest in Research. (1990). Guidelines for dealing with faculty conflicts of commitment and conflicts of interest in research. Academic Medicine, 65, 488–496.
2. Allman, R. L. (2003).The relationship between physicians and the pharmaceutical industry. HEC Forum, 15, 155–170.
3. Barrett, D. (2000). Lawyer busted in stocks bribe. New York Post. November 21.
4. Bekelman, J. E., Li, Y., and Gross, C. P. (2003). Scope and impact of financial conflicts of interest in biomedical research. Journal of the American Medical Association, 289, 454–464.
5. Berger, J. T. (2003). Pharmaceutical industry influences on physician prescribing: Gifts, quasi-gifts, and patient-directed gifts. American Journal of Bioethics, 3, 56–57.
6. Bernat, J. L., Goldstein, M. L., and Ringel, S. P. (1998). Conflicts of interest in neurology. Neurology, 50, 327–331.
7. Bero, L. A. (1998). Disclosure policies for gifts from industry to academic faculty. Journal of the American Medical Association, 279, 1031–1032.
8. Berton, L. (1986). CPA self-regulation: A contradiction in terms? Wall Street Journal, August 19: 1.
9. Blake, D. A. (1992). The opportunities and problems of commercial ventures: the university view. In R. J. Porter and T. E. Malone (Eds.), Biomedical Research: Collaboration and Conflict of Interest. Baltimore and London: Johns Hopkins.
10. Blumenthal, D., Causino, N., Campbell, E., and Louis, K. S. (1996). Relationships between academic and industry in the life sciences – an industry survey. New England Journal of Medicine, 334, 368–373.
11. Boyd, E., Cho, M., and Bero, L. (2003). Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Academic Medicine, 78, 769–774.
12. Brett, A. S. (2003). Cheap trinkets, effective marketing: small gifts from drug companies to physicians. American Journal of Bioethics, 3, 52–53.
13. Brett, A. S., Burr, W., and Moloo, J. (2003). Are gifts from pharmaceutical companies ethically problematic? Archives of Internal Medicine, 163, 2213–2218.
14. Brody, B. A. (1996). Conflicts of interest and the validity of clinical trials. In R. G. Spece, D. S. Shimm, and A. E. Buchanan (Eds.), Conflicts of interest in clinical research and practice. New York: Oxford University Press.
15. Business Editors. (2002). Technical findings for water program reaffirmed. Business Wire, March 2: 1.
16. Cantekin, E., and McGuire, T. W. (1989). Biomedical information, peer reviews, and conflict of interest as they influence public health (abstract). In Guarding the guardians: Research on peer review. The First International Congress on Peer Review in Biomedical Publication, May 10–12: 19–20.
17. Cho, M. K., and Billings, P. (1997). Conflict of interest and institutional review boards. Journal of Investigative Medicine, 45, 154–159.
18. Cho, M.K., Ryo, S., Schissel, A., and Rennie, D. (2000).Policies on faculty conflicts of interest at US universities. Journal of the American Medical Association, 284, 2203–2208.
19. Chren, M. M., and Landefeld, C. S. (1994). Physicians’ behavior and their interactions with drug companies. Journal of the American Medical Association, 271, 684–689.
20. Council of Ethical and Judicial Affairs of the American Medical Association. (1991). Gifts to physicians from industry. Journal of the American Medical Association, 256, 501.
21. Dana, J., and Loewenstein, G. (2003). A social science perspective on gifts to physicians from industry. Journal of the American Medical Association, 290, 252–256.
22. Davidoff, F. (1997).Where’s the bias? Annals of Internal Medicine, 126, 986–988.
23. DeAngelis, C.D. (2000). Conflict of interest and public trust. Journal of the American Medical Association, 284, 2237–2238.
24. Donaldson M. S., and Capron, A. M. (1991). Patient outcomes research teams: Managing conflict of interest. Washington, D.C.: National Academy Press.
25. Donaldson M. S., and Capron, A. M. (1991). Whistle blows at BCCI: Sounds of silence. Bank Systems and Technology, 28, 30–32.
26. Donaldson M. S., and Capron, A. M. (2003). Editorial procedures reviewed. Nature Cell Biology, 5, 583–584.
27. Emanuel, E. J., and Steiner, D. (1995). Institutional conflict of interest. New England Journal of Medicine, 322, 262–268.
28. Fogarty, T., and Ravenscroct, S. (1999). Making accounting knowledge: Peering at power. Panopticon, California State University at Stanislaus, 1–18.
29. Foster, R. S. (2003). Conflicts of interest: Recognition, disclosure and management. Journal of the American College of Surgeons, 196, 505–517.
30. Frankel, M. S. (1996). Perception, reality and the political context of conflict of interest in university-industry relationships. Academic Medicine, 71, 1297–1304.
31. Friedberg, M., Saffran, B., Sinson, T. J., Nelson, W., and Bennett, C. L. (1999). Evaluation of conflict of interest in economic analyses of new drugs used in oncology. Journal of the American Medical Association, 282, 1453–1457.
32. Friedman, P. J. (1990). We need to find new ways to help scientists avoid ethical problems without overly limiting research. Chronicle of Higher Education, October 31: A48.
33. Gatehouse, J. (2001). Journals push back at drug giants. National Post, August 13: A1.
34. Gibbons, R. V. et al. (1998). A comparison of physicians’ and patients’ attitudes toward pharmaceutical industry gifts. Journal of General Internal Medicine, 13, 151–154.
35. Goldrick, B. A., Larson, E., and Lyons, D. (1995). Conflict of interest in academia. Image the Journal of Nursing Scholarship, 27, 65–69.
36. Goodman, B. (2003). All rationalizations large and small. American Journal of Bioethics, 3, 57–58.
37. Grace, S. (1998). Physicians disagree on the ethics of self-referral. Times-Picayune, May 10:A12.
38. Gray, B. H. (1991). The profit motive and patient care: The changing accountability of doctors and hospitals. Cambridge, MA: Harvard University Press.
39. Green, R. M. (1990). Physicians, entrepreneurism and the problem of conflict of interest. Theoretical Medicine, 11, 287–300.
40. Gunderson, M. (1997). Eliminating conflicts of interest in managed care organizations through disclosure and consent. Journal of Law, Medicine and Ethics, 25, 5–15.
41. Hensley, S. (2002). Drug group sets guidelines to curb hard-sell tactics. Wall Street Journal, April 19: A2.
42. Hilts, P. J. (2000). Medical-research official cites ethics woes. New York Times. August 17: A20.
43. Hodges, B. (1995). Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. Canadian Medical Association Journal, 153, 553–559.
44. Horrobin, D. (1989).The philosophical basis of peer review (abstract). In guarding the guardians: Research on peer review. The First International Congress on Peer Review in Biomedical Publication. May 10–12: 24.
45. Horton, R. (1997). Conflicts of interest in clinical research: opprobrium or obsession. Lancet, 349, 1112–1113.
46. James, A., and Horton, R. (2003). The Lancet’s policy on conflicts of interest. Lancet, 361, 8–9.
47. Johns, M. M. E., Barnes, M., and Florencio, P. S. (2003). Restoring balance to industry-academic relationships in an era of institutional financial conflicts of interest. Journal of the American Medical Association, 289, 741–746.
48. Kassirer, J. P. (2000). Financial indigestion. Journal of the American Medical Association, 284, 2156–2157.
49. Kassirer, J. P., and Angell, M. (1993). Financial conflicts of interest in biomedical research. New England Journal of Medicine, 329, 570–571.
50. Katz, D., Caplan, A. L., and Merz, J. F. (2003). All gifts large and small. American Journal of Bioethics, 3, 39–46.
51. King, C. R., McGuire, D. B., Longman, A. J., and Carroll-Johnson, R. M. (1997). Peer review, authorship, ethics and conflict of interest. Image, 29, 163–167.
52. Korenman, S. G. (1993). Conflicts of interest and commercialization of research. Academic Medicine, 9: S18–S22.
53. Korn, D. (2000). Conflicts of interest in biomedical research. Journal of the American Medical Association, 284, 2234–2237.
54. Kraus, W. (1999). Certification – improvement thanks to peer review. Cost Engineering, 41, 22–24.
55. Kravetz, A. (2000). Judge to rule on bribery charge in Mitsubishi case. Peoria Star Journal. January 21.
56. Krimsky, S., and Rothenberg, L. S. (1998). Financial interest and its disclosure in scientific publications. Journal of the American Medical Association, 280, 225–226.
57. Krimsky, S. (1999). Conflict of interest and cost-effectiveness analysis. Journal of the American Medical Association, 282, 1474–1475.
58. Latham, S. (2001). Conflict of interest in medical practice. In M.Davis and A. Stark (Eds.), Conflict of interest and the professions. New York: Oxford University Press.
59. Lemmens, T. L., and Singer, P. A. (1998). Bioethics for clinicians: Conflict of interest in research, education and patient care. Canadian Medical Association Journal, 159, 960–965.
60. Levinsky, N. G. (2002). Nonfinancial Conflicts of Interest in Research. New England Journal of Medicine, 247, 759–761.
61. Lewis, R. (2002). Rules stall quick hire of Boston Highway megaproject reviewer. Knight Ridder Tribune Business News, February 26: 1.
62. Lexchin, J. (1993). Interactions between physicians and the pharmaceutical industry: What does the literature say? Canadian Medical Association Journal, 149, 1401–1407.
63. Lock, S. (1994). Does editorial peer review work? Annals of Internal Medicine, 121, 60–61.
64. McDowell, T.N. (1989). Physician self referral arrangements: Legitimate business or unethical “entrepreneurialism.” American Journal of Law and Medicine, 15, 61–109.
65. McKinney, W. P. et al. (1990). Attitudes of internal medicine faculty toward professional interaction with pharmaceutical sales representatives. Journal of the American Medical Association, 264, 1693–1697.
66. McNutt, K. (1999). Conflict of interest (nutrition research). Journal of the American Diet Association, 99, 1–4.
67. Mancuso, A. J. (1991). The road to quality. CPA Journal, 61, 94.
68. Mansfield, P. R. (2003). Bribes for doctors: A gift for bioethicists? American Journal of Bioethics, 3, 47–48.
69. Marshall E. (1992). When does intellectual passion become conflict of interest? Science, 257, 621.
70. Miller, T. E., and Sage, W. M. (1999). Disclosing physician financial incentives. Journal of the American Medical Association, 281, 1424–1430.
71. Moore, N.J. (1996). Entrepreneurial doctors and lawyers: Regulating business activities in the medical and legal professions. In R. G. Spece, D. S. Shimm, and A. E. Buchanan (Eds.), Conflicts of interest in clinical research and practice. New York: Oxford University Press.
72. Morin, K., and Morse, L. J. (2003). The ethics of pharmaceutical gift-giving: The role of a professional association. American Journal of Bioethics, 3, 54–55.
73. Morreim, E. H. (1996). Conflict of interest for physician entrepreneurs. In R. G. Spece, D. S. Shimm, and A. E. Buchanan (Eds.), Conflicts of interest in clinical research and practice. New York: Oxford University Press.
74. Murray, D. (2002). Gifts: What’s all the fuss about? Medical Economics, October 11.
75. Omenn, G. S. (1983). University-corporate relations in science and technology. In Partners in the research enterprise: A national conference on university-corporate relations in science and technology. University of Pennsylvania, Dec. 14–16, 1982; Philadelphia: University of Pennsylvania Press.
76. Parmley, W. W. (1992). Conflict of interest: An issue for authors and reviewers. Journal of the American College of Cardiology, 20, 1017.
77. Parmley, W.W. (2000). Full disclosure: The antidote to conflict of interest. Journal of the American College of Cardiology, 25, 1693.
78. Patterson, K. (2002). What doctors don’t know (almost everything). New York Times Magazine, May 5.
79. Pisetsky, D. S., Hunder, G. G., and Gravallese, E. (2003). New policy on disclosure of interest for American College of Rheumatology journals. Arthritis and Rheumatism, 48, 863–875.
80. Porter, R. J. (1992). Conflict of interest in research: Personal gain – the seeds of conflict. In R. J. Porter and T. E. Malone (Eds.), Biomedical research: Collaboration and conflict of interest. Baltimore and London: Johns Hopkins University Press.
81. Relman, A. S. (1985). Dealing with conflicts of interest. New England Journal of Medicine, 313, 749–751.
82. Relman, A. S. (1989). Economic incentives in clinical investigation. (1989). New England Journal of Medicine, 320, 933–934.
83. Rennie, D., Flanagin, A., and Glass, R. M. (1991). Conflicts of interest in the publication of science. Journal of the American Medical Association, 266, 266–267.
84. Rennie, D. (1993). More peering into editorial peer review. Journal of the American Medical Association, 270, 2856–2858.
85. Rhodes, R., and Capozzi, J. D. (2003). The invisible influence of industry inducements. American Journal of Bioethics, 3, 65–67.
86. Rodwin, M. (1993). Medicine, money, and morals. New York: Oxford University Press.
87. Rodwin, M., and Okamoto, A. (2000). Physicians’ conflict of interest in Japan and the United States: Lessons for the United States. Journal of Health Politics, Policy and Law, 25, 343–375.
88. Rothman, K. J. (1993). Conflict of interest: The new McCarthyism in science. Journal of the American Medical Association, 269, 2782–2784.
89. Rumsey, T. S. (1999). One editor’s views on conflict of interest. Journal of Animal Science, 77, 2379–2383.
90. Sadovi, C. (2002). Lawyer accused of seeking bribe. Chicago Sun-Times, April 4.
91. Sage, W. M. (1999). Regulating through information: Disclosure laws and American health care. Columbia Law Review, 99, 1701–1829.
92. Scanlon, B. (2003). Safety versus secrecy; Physician peer reviews conflict with patients’ right to know, critics say. Rocky Mountain News, Dec. 6: 25A.
93. Shimm, D. S., and Spece, R. G. (1991). Industry reimbursement for entering patients into clinical trials: Legal and ethical issues. Annals of Internal Medicine, 115, 148–151.
94. Shimm, D. S., Spece, R. G., and DiGregorio, M. B. (1996). Conflicts of interests in relationships between physicians and the pharmaceutical industry. In R. G. Spece, D. S. Shimm, and A. E. Buchanan (Eds.), Conflicts of interest in clinical research and practice. New York: Oxford University Press.
95. Shipp, A. C. (1992). How to control conflict of interest. In R. J. Porter and T. E. Malone (Eds.), Biomedical research: Collaboration and conflict of interest. Baltimore and London: Johns Hopkins University Press.
96. Smith, R. (1994). Conflict of interest and the BMJ. British Medical Journal, 308, 4–5.
97. Sollitto, S. et al. (2003). Intrinsic conflicts of interest in clinical research: A need for disclosure. Kennedy Institute of Ethics Journal, 13, 83–91.
98. Southgate, M. (1987). Conflict of interest and the peer review process. Journal of the American Medical Association, 258, 1375.
99. Steinman, M.A. (2000). Gifts to physicians in the consumer marketing era. Journal of the American Medical Association, 284, 2243.
100. Stelfox, H. T., Chua, G., O’Rourke, K., and Dresky, A. S. (1998). Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine, 338, 101–106.
101. Taylor, M. (1999). Healthcare struggles with Stark reality. Modern Healthcare, July 5: 30–31.
102. Thompson, D. F. (1993). Understanding financial conflicts of interest. New England Journal of Medicine, 329, 573–576.
103. U.S. House of Representatives. (1989). Committee on Government Operations, Subcommittee on Human Resources and Intergovernmental Relations. Hearings: Is science for sale? Conflicts of interest vs. the public interest. 101st Congress, 1st Session, June 13.
104. U.S. House of Representatives. (1988). Committee on the Judiciary. Subcommittee on Administrative Law and Governmental Relations. Post-employment restrictions for federal officers and employees. 100th Congress, 2nd Session, May 4.
105. U.S. House of Representatives. (1986). Committee on Science and Technology, Task Force on Science Policy. Hearings. 99th Session, 2nd Congress. April 8–10.
106. U.S. House of Representatives. (1985). Committee on Science and Technology, Task Force on Science Policy. Hearings: Science in the political process. 99th Congress, 1st Session, June 25, 26.
107. U.S. Office of Government Ethics. (1986). Letter to an employee (86 × 10), August 8.
108. Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association, 19, 373–380.
109. Welch, S. J. (1997). Conflict of interest and financial disclosure. Chest, 112, 865–867.
110. West Bank Bureau. (2001). Engineer receives fine, 3 years probation. NewOrleans Times Picayune, July 21: BW1.
111. Wilkinson, P. (1993). “Self-referral”: A potential conflict of interest. British Medical Journal, 306, 1083–1084.
112. Wilson, C. (2002). Contractor to pay back $145,000; Woman sentenced in bribery case. South Florida Sun-Sentinel, March 10: 5B.
113. Witt, M., and Gostin, L. (1994). Conflict of interest dilemmas in biomedical research. Journal of the American Medical Association, 271, 547–551.
114. Wyden, R. (1987). When doctors sell drugs: A conflict of interest. Washington Post, April 28: Z6.
115. Wyngaarden, J. (1983). Government, industry and academia:ABermuda triangle in partners in the research enterprise: A National Conference on University-Corporate Relations in Science and Technology, University of Pennsylvania, December 14–16, 1982. Philadelphia: University of Pennsylvania Press.
116. Zientek, D. M. (2003). Physician entrepreneurs, self-referral and conflicts of interest: an overview. HEC Forum, 15, 111–133.